S&P 500   3,122.03 (+0.05%)
DOW   28,036.22 (+0.11%)
QQQ   203.07 (+0.08%)
AAPL   267.10 (+0.50%)
FB   197.40 (+1.18%)
MSFT   150.34 (+0.25%)
GOOGL   1,319.84 (-1.03%)
AMZN   1,752.53 (+0.75%)
CGC   14.22 (-7.24%)
NVDA   212.28 (+3.96%)
MU   47.82 (+0.23%)
BABA   184.61 (-0.47%)
GE   11.44 (-0.69%)
TSLA   349.99 (-0.62%)
T   39.63 (+0.33%)
AMD   39.88 (+3.42%)
ACB   2.28 (-16.48%)
F   8.95 (+0.00%)
PRI   131.10 (+0.37%)
NFLX   302.57 (+2.56%)
BAC   32.96 (+0.09%)
GILD   64.29 (-1.20%)
DIS   147.65 (+2.06%)
S&P 500   3,122.03 (+0.05%)
DOW   28,036.22 (+0.11%)
QQQ   203.07 (+0.08%)
AAPL   267.10 (+0.50%)
FB   197.40 (+1.18%)
MSFT   150.34 (+0.25%)
GOOGL   1,319.84 (-1.03%)
AMZN   1,752.53 (+0.75%)
CGC   14.22 (-7.24%)
NVDA   212.28 (+3.96%)
MU   47.82 (+0.23%)
BABA   184.61 (-0.47%)
GE   11.44 (-0.69%)
TSLA   349.99 (-0.62%)
T   39.63 (+0.33%)
AMD   39.88 (+3.42%)
ACB   2.28 (-16.48%)
F   8.95 (+0.00%)
PRI   131.10 (+0.37%)
NFLX   302.57 (+2.56%)
BAC   32.96 (+0.09%)
GILD   64.29 (-1.20%)
DIS   147.65 (+2.06%)
S&P 500   3,122.03 (+0.05%)
DOW   28,036.22 (+0.11%)
QQQ   203.07 (+0.08%)
AAPL   267.10 (+0.50%)
FB   197.40 (+1.18%)
MSFT   150.34 (+0.25%)
GOOGL   1,319.84 (-1.03%)
AMZN   1,752.53 (+0.75%)
CGC   14.22 (-7.24%)
NVDA   212.28 (+3.96%)
MU   47.82 (+0.23%)
BABA   184.61 (-0.47%)
GE   11.44 (-0.69%)
TSLA   349.99 (-0.62%)
T   39.63 (+0.33%)
AMD   39.88 (+3.42%)
ACB   2.28 (-16.48%)
F   8.95 (+0.00%)
PRI   131.10 (+0.37%)
NFLX   302.57 (+2.56%)
BAC   32.96 (+0.09%)
GILD   64.29 (-1.20%)
DIS   147.65 (+2.06%)
S&P 500   3,122.03 (+0.05%)
DOW   28,036.22 (+0.11%)
QQQ   203.07 (+0.08%)
AAPL   267.10 (+0.50%)
FB   197.40 (+1.18%)
MSFT   150.34 (+0.25%)
GOOGL   1,319.84 (-1.03%)
AMZN   1,752.53 (+0.75%)
CGC   14.22 (-7.24%)
NVDA   212.28 (+3.96%)
MU   47.82 (+0.23%)
BABA   184.61 (-0.47%)
GE   11.44 (-0.69%)
TSLA   349.99 (-0.62%)
T   39.63 (+0.33%)
AMD   39.88 (+3.42%)
ACB   2.28 (-16.48%)
F   8.95 (+0.00%)
PRI   131.10 (+0.37%)
NFLX   302.57 (+2.56%)
BAC   32.96 (+0.09%)
GILD   64.29 (-1.20%)
DIS   147.65 (+2.06%)
Log in

Vapotherm Stock Price, Forecast & Analysis (NYSE:VAPO)

$11.59
+0.70 (+6.43 %)
(As of 11/18/2019 04:00 PM ET)
Today's Range
$10.92
Now: $11.59
$11.96
50-Day Range
$8.07
MA: $9.94
$12.60
52-Week Range
$7.60
Now: $11.59
$24.63
Volume232,399 shs
Average Volume109,964 shs
Market Capitalization$244.36 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Vapotherm, Inc., a medical technology company, focuses on the development and commercialization of proprietary Hi-VNI technology products used to treat patients of various ages suffering from respiratory distress worldwide. The company offers precision flow systems, such as Precision Flow Hi-VNI, Precision Flow Plus, Precision Flow Classic, and Precision Flow Heliox that use Hi-VNI technology to deliver heated, humidified, and oxygenated air at a high velocity to patients through a small-bore nasal interface. It also provides companion products, including Vapotherm Transfer Unit and Q50 compressor; and disposable products comprising single-use disposables and nasal interfaces. The company sells its products to hospitals. Vapotherm, Inc. was founded in 1993 and is headquartered in Exeter, New Hampshire.

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone603-658-0411

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$42.38 million
Book Value$3.09 per share

Profitability

Net Income$-42,470,000.00
Net Margins-110.06%

Miscellaneous

Employees276
Market Cap$244.36 million
Next Earnings Date3/10/2020 (Estimated)
OptionableNot Optionable

Receive VAPO News and Ratings via Email

Sign-up to receive the latest news and ratings for VAPO and its competitors with MarketBeat's FREE daily newsletter.


Vapotherm (NYSE:VAPO) Frequently Asked Questions

What is Vapotherm's stock symbol?

Vapotherm trades on the New York Stock Exchange (NYSE) under the ticker symbol "VAPO."

How were Vapotherm's earnings last quarter?

Vapotherm Inc (NYSE:VAPO) posted its quarterly earnings results on Tuesday, November, 5th. The company reported ($0.65) EPS for the quarter, topping the consensus estimate of ($0.76) by $0.11. The company earned $10.81 million during the quarter, compared to analysts' expectations of $11.10 million. Vapotherm had a negative net margin of 110.06% and a negative return on equity of 107.95%. View Vapotherm's Earnings History.

When is Vapotherm's next earnings date?

Vapotherm is scheduled to release their next quarterly earnings announcement on Tuesday, March 10th 2020. View Earnings Estimates for Vapotherm.

What price target have analysts set for VAPO?

4 equities research analysts have issued 12 month price objectives for Vapotherm's stock. Their forecasts range from $12.00 to $27.00. On average, they anticipate Vapotherm's stock price to reach $19.50 in the next year. This suggests a possible upside of 68.2% from the stock's current price. View Analyst Price Targets for Vapotherm.

What is the consensus analysts' recommendation for Vapotherm?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Vapotherm in the last year. There are currently 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Vapotherm.

Has Vapotherm been receiving favorable news coverage?

Press coverage about VAPO stock has trended very negative on Monday, InfoTrie Sentiment reports. The research firm identifies positive and negative media coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. Vapotherm earned a media sentiment score of -3.0 on InfoTrie's scale. They also gave media stories about the company a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an effect on the stock's share price in the near term. View News Stories for Vapotherm.

Are investors shorting Vapotherm?

Vapotherm saw a increase in short interest during the month of October. As of October 15th, there was short interest totalling 567,600 shares, an increase of 7.0% from the September 15th total of 530,500 shares. Based on an average trading volume of 215,000 shares, the days-to-cover ratio is currently 2.6 days. Currently, 5.0% of the company's shares are sold short. View Vapotherm's Current Options Chain.

Who are some of Vapotherm's key competitors?

What other stocks do shareholders of Vapotherm own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Vapotherm investors own include Home Depot (HD), Alibaba Group (BABA), CVS Health (CVS), Cisco Systems (CSCO), Honeywell International (HON), Thermo Fisher Scientific (TMO), QUALCOMM (QCOM), Johnson & Johnson (JNJ), Mcdonald's (MCD) and Procter & Gamble (PG).

Who are Vapotherm's key executives?

Vapotherm's management team includes the folowing people:
  • Mr. Joseph F. Army, CEO, Pres & Director (Age 55)
  • Mr. William Niland, Founder
  • Mr. John Landry, VP, CFO, Sec. & Treasurer (Age 47)
  • Mr. John Coolidge, VP of Operations (Age 58)
  • Mr. Anthony Ten Haagen, VP of Legal & Compliance

When did Vapotherm IPO?

(VAPO) raised $60 million in an initial public offering (IPO) on Wednesday, November 14th 2018. The company issued 4,000,000 shares at a price of $14.00-$16.00 per share. BofA Merrill Lynch and William Blair served as the underwriters for the IPO and Canaccord Genuity and BTIG were co-managers.

Who are Vapotherm's major shareholders?

Vapotherm's stock is owned by many different of retail and institutional investors. Top institutional investors include Taylor Frigon Capital Management LLC (0.72%), Arnhold LLC (0.29%), Rhumbline Advisers (0.07%) and Tower Research Capital LLC TRC (0.03%). Company insiders that own Vapotherm stock include Anthony L Arnerich, Elizabeth H Weatherman, Healthcare Holding BV Gilde, James W Liken, John Landry, Joseph Army and Michael Mcqueen. View Institutional Ownership Trends for Vapotherm.

Which major investors are buying Vapotherm stock?

VAPO stock was purchased by a variety of institutional investors in the last quarter, including Taylor Frigon Capital Management LLC, Rhumbline Advisers, Arnhold LLC and Tower Research Capital LLC TRC . Company insiders that have bought Vapotherm stock in the last two years include Anthony L Arnerich, Elizabeth H Weatherman, Healthcare Holding BV Gilde, James W Liken, John Landry, Joseph Army and Michael Mcqueen. View Insider Buying and Selling for Vapotherm.

How do I buy shares of Vapotherm?

Shares of VAPO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Vapotherm's stock price today?

One share of VAPO stock can currently be purchased for approximately $11.59.

How big of a company is Vapotherm?

Vapotherm has a market capitalization of $244.36 million and generates $42.38 million in revenue each year. The company earns $-42,470,000.00 in net income (profit) each year or ($13.83) on an earnings per share basis. Vapotherm employs 276 workers across the globe.View Additional Information About Vapotherm.

What is Vapotherm's official website?

The official website for Vapotherm is http://www.vapotherm.com/.

How can I contact Vapotherm?

Vapotherm's mailing address is 100 DOMAIN DRIVE, EXETER NH, 03833. The company can be reached via phone at 603-658-0411 or via email at [email protected]


MarketBeat Community Rating for Vapotherm (NYSE VAPO)

Community Ranking:  2.0 out of 5 (star star)
Outperform Votes:  42 (Vote Outperform)
Underperform Votes:  62 (Vote Underperform)
Total Votes:  104
MarketBeat's community ratings are surveys of what our community members think about Vapotherm and other stocks. Vote "Outperform" if you believe VAPO will outperform the S&P 500 over the long term. Vote "Underperform" if you believe VAPO will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 11/18/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel